Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| February 13, 2024 | 7.782B |
| February 12, 2024 | 7.782B |
| February 09, 2024 | 7.782B |
| February 08, 2024 | 7.782B |
| February 07, 2024 | 7.335B |
| February 06, 2024 | 7.324B |
| February 05, 2024 | 7.268B |
| February 02, 2024 | 7.257B |
| February 01, 2024 | 7.284B |
| January 31, 2024 | 7.273B |
| January 30, 2024 | 7.292B |
| January 29, 2024 | 7.300B |
| January 26, 2024 | 7.340B |
| January 25, 2024 | 7.321B |
| January 24, 2024 | 7.321B |
| January 23, 2024 | 7.305B |
| January 22, 2024 | 7.332B |
| January 19, 2024 | 7.327B |
| January 18, 2024 | 7.329B |
| January 17, 2024 | 7.345B |
| January 16, 2024 | 7.356B |
| January 12, 2024 | 7.391B |
| January 11, 2024 | 7.375B |
| January 10, 2024 | 7.391B |
| January 09, 2024 | 7.425B |
| Date | Value |
|---|---|
| January 08, 2024 | 7.415B |
| January 05, 2024 | 7.361B |
| January 04, 2024 | 7.327B |
| January 03, 2024 | 7.321B |
| January 02, 2024 | 7.364B |
| December 29, 2023 | 7.361B |
| December 28, 2023 | 7.377B |
| December 27, 2023 | 7.420B |
| December 26, 2023 | 7.415B |
| December 22, 2023 | 7.375B |
| December 21, 2023 | 7.375B |
| December 20, 2023 | 7.313B |
| December 19, 2023 | 7.417B |
| December 18, 2023 | 7.313B |
| December 15, 2023 | 7.308B |
| December 14, 2023 | 7.313B |
| December 13, 2023 | 7.441B |
| December 12, 2023 | 7.377B |
| December 11, 2023 | 7.361B |
| December 08, 2023 | 7.244B |
| December 07, 2023 | 7.287B |
| December 06, 2023 | 7.279B |
| December 05, 2023 | 7.244B |
| December 04, 2023 | 7.247B |
| December 01, 2023 | 7.273B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
0.8276M
Minimum
May 31 2019
7.782B
Maximum
Feb 08 2024
1.331B
Average
798.96M
Median
Enterprise Value Benchmarks
| AbbVie Inc | 345.20B |
| Pfizer Inc | 215.90B |
| Johnson & Johnson | 366.66B |
| Merck & Co Inc | 351.00B |
| Cerevel Therapeutics Holdings Inc | 7.073B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 30.75M |
| Revenue (Quarterly) | 113.42M |
| Total Expenses (Quarterly) | 87.47M |
| EPS Diluted (Quarterly) | 0.10 |
| Gross Profit Margin (Quarterly) | 98.10% |
| Profit Margin (Quarterly) | 27.11% |